{"disease":{"id":"opioid-induced-hyperalgesia","name":"opioid induced hyperalgesia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04059978","title":"Pain Response to Cannabidiol in Opioid-induced Hyperalgesia, Acute Nociceptive Pain and Allodynia By Using a Model Mimicking Acute Pain in Healthy Adults","phase":"NA","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT06096181","title":"Propofol + Remifentanil vs. Propofol + Dexmedetomidine in Adolescent Idiopathic Scoliosis Patients Having Spine Surgery","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":13,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}